Scynexis Current Deferred Revenue vs Other Stockholder Equity Analysis

SCYX Stock

USD 2.41 0.15 6.64%

Scynexis financial indicator trend analysis is much more than just breaking down Scynexis prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Scynexis is a good investment. Please check the relationship between Scynexis Current Deferred Revenue and its Other Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scynexis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Scynexis Stock please use our How to Invest in Scynexis guide.

Current Deferred Revenue vs Other Stockholder Equity

Current Deferred Revenue vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Scynexis Current Deferred Revenue account and Other Stockholder Equity. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Scynexis' Current Deferred Revenue and Other Stockholder Equity is 0.51. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Scynexis, assuming nothing else is changed. The correlation between historical values of Scynexis' Current Deferred Revenue and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Scynexis are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Current Deferred Revenue i.e., Scynexis' Current Deferred Revenue and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.51

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Other Stockholder Equity

Most indicators from Scynexis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Scynexis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scynexis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Scynexis Stock please use our How to Invest in Scynexis guide.At this time, Scynexis' Tax Provision is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 1.25 in 2024, whereas Selling General Administrative is likely to drop slightly above 21.9 M in 2024.

Scynexis fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.27	0.69	0.26	0.7	0.74	-0.5	0.48	-0.7	-0.88	0.82	0.8	0.42	0.3	0.73	0.45	0.95	0.42	0.72	0.77	-0.08	0.45	0.95	0.72	-0.47	0.99
Short Long Term Debt Total	0.27		0.31	0.36	-0.2	0.27	0.22	-0.01	0.04	-0.44	0.35	0.35	0.22	0.67	0.5	0.87	0.29	-0.08	0.46	0.72	-0.21	-0.1	0.3	0.7	0.25	0.25
Other Current Liab	0.69	0.31		0.66	0.27	0.75	-0.18	0.66	-0.61	-0.7	0.47	0.72	0.21	0.23	0.52	0.44	0.71	0.19	0.49	0.7	0.02	0.2	0.68	0.76	-0.18	0.7
Total Current Liabilities	0.26	0.36	0.66		-0.22	0.68	0.41	0.52	-0.08	-0.35	0.32	0.28	0.4	0.39	0.49	0.33	0.18	0.17	0.33	0.53	-0.23	0.17	0.25	0.69	0.41	0.19
Total Stockholder Equity	0.7	-0.2	0.27	-0.22		0.4	-0.64	0.11	-0.61	-0.6	0.43	0.48	0.48	-0.17	0.54	-0.07	0.66	0.66	0.62	0.18	0.02	0.7	0.64	0.11	-0.63	0.71
Other Liab	0.74	0.27	0.75	0.68	0.4		-0.07	0.76	-0.53	-0.82	0.76	0.67	0.58	0.35	0.78	0.39	0.68	0.45	0.69	0.75	-0.11	0.51	0.75	0.8	-0.05	0.7
Property Plant And Equipment Net	-0.5	0.22	-0.18	0.41	-0.64	-0.07		-0.01	0.42	0.45	-0.33	-0.32	0.12	-0.11	-0.13	-0.07	-0.6	-0.12	-0.21	-0.12	0.19	-0.13	-0.58	-0.01	1.0	-0.57
Current Deferred Revenue	0.48	-0.01	0.66	0.52	0.11	0.76	-0.01		-0.56	-0.51	0.61	0.58	0.08	0.1	0.23	0.16	0.5	0.07	0.18	0.54	0.12	0.12	0.51	0.59	-0.01	0.49
Net Debt	-0.7	0.04	-0.61	-0.08	-0.61	-0.53	0.42	-0.56		0.51	-0.41	-0.91	0.01	0.0	-0.28	0.02	-0.8	-0.03	-0.22	-0.39	-0.28	-0.11	-0.6	-0.35	0.4	-0.76
Retained Earnings	-0.88	-0.44	-0.7	-0.35	-0.6	-0.82	0.45	-0.51	0.51		-0.87	-0.69	-0.52	-0.43	-0.83	-0.64	-0.86	-0.49	-0.85	-0.84	0.17	-0.51	-0.95	-0.8	0.43	-0.88
Accounts Payable	0.82	0.35	0.47	0.32	0.43	0.76	-0.33	0.61	-0.41	-0.87		0.59	0.44	0.5	0.69	0.55	0.76	0.36	0.66	0.81	-0.22	0.38	0.88	0.76	-0.3	0.79
Cash	0.8	0.35	0.72	0.28	0.48	0.67	-0.32	0.58	-0.91	-0.69	0.59		0.1	0.31	0.49	0.36	0.89	0.02	0.4	0.71	0.11	0.09	0.72	0.67	-0.28	0.84
Non Current Assets Total	0.42	0.22	0.21	0.4	0.48	0.58	0.12	0.08	0.01	-0.52	0.44	0.1		0.14	0.83	0.21	0.21	0.9	0.84	0.35	-0.38	0.91	0.37	0.39	0.12	0.31
Non Currrent Assets Other	0.3	0.67	0.23	0.39	-0.17	0.35	-0.11	0.1	0.0	-0.43	0.5	0.31	0.14		0.48	0.64	0.32	-0.15	0.3	0.6	-0.59	-0.17	0.42	0.6	-0.08	0.27
Other Assets	0.73	0.5	0.52	0.49	0.54	0.78	-0.13	0.23	-0.28	-0.83	0.69	0.49	0.83	0.48		0.51	0.6	0.66	0.94	0.69	-0.31	0.68	0.74	0.7	-0.11	0.66
Long Term Debt	0.45	0.87	0.44	0.33	-0.07	0.39	-0.07	0.16	0.02	-0.64	0.55	0.36	0.21	0.64	0.51		0.47	0.05	0.56	0.85	-0.3	0.01	0.52	0.8	-0.05	0.44
Cash And Short Term Investments	0.95	0.29	0.71	0.18	0.66	0.68	-0.6	0.5	-0.8	-0.86	0.76	0.89	0.21	0.32	0.6	0.47		0.23	0.59	0.76	-0.02	0.27	0.92	0.69	-0.57	0.99
Net Receivables	0.42	-0.08	0.19	0.17	0.66	0.45	-0.12	0.07	-0.03	-0.49	0.36	0.02	0.9	-0.15	0.66	0.05	0.23		0.76	0.18	-0.29	0.98	0.37	0.19	-0.13	0.34
Common Stock Shares Outstanding	0.72	0.46	0.49	0.33	0.62	0.69	-0.21	0.18	-0.22	-0.85	0.66	0.4	0.84	0.3	0.94	0.56	0.59	0.76		0.66	-0.26	0.78	0.74	0.64	-0.2	0.66
Non Current Liabilities Total	0.77	0.72	0.7	0.53	0.18	0.75	-0.12	0.54	-0.39	-0.84	0.81	0.71	0.35	0.6	0.69	0.85	0.76	0.18	0.66		-0.22	0.18	0.78	0.98	-0.09	0.75
Inventory	-0.08	-0.21	0.02	-0.23	0.02	-0.11	0.19	0.12	-0.28	0.17	-0.22	0.11	-0.38	-0.59	-0.31	-0.3	-0.02	-0.29	-0.26	-0.22		-0.24	-0.12	-0.24	0.18	-0.02
Other Current Assets	0.45	-0.1	0.2	0.17	0.7	0.51	-0.13	0.12	-0.11	-0.51	0.38	0.09	0.91	-0.17	0.68	0.01	0.27	0.98	0.78	0.18	-0.24		0.4	0.2	-0.13	0.38
Other Stockholder Equity	0.95	0.3	0.68	0.25	0.64	0.75	-0.58	0.51	-0.6	-0.95	0.88	0.72	0.37	0.42	0.74	0.52	0.92	0.37	0.74	0.78	-0.12	0.4		0.72	-0.56	0.94
Total Liab	0.72	0.7	0.76	0.69	0.11	0.8	-0.01	0.59	-0.35	-0.8	0.76	0.67	0.39	0.6	0.7	0.8	0.69	0.19	0.64	0.98	-0.24	0.2	0.72		0.02	0.69
Property Plant And Equipment Gross	-0.47	0.25	-0.18	0.41	-0.63	-0.05	1.0	-0.01	0.4	0.43	-0.3	-0.28	0.12	-0.08	-0.11	-0.05	-0.57	-0.13	-0.2	-0.09	0.18	-0.13	-0.56	0.02		-0.55
Total Current Assets	0.99	0.25	0.7	0.19	0.71	0.7	-0.57	0.49	-0.76	-0.88	0.79	0.84	0.31	0.27	0.66	0.44	0.99	0.34	0.66	0.75	-0.02	0.38	0.94	0.69	-0.55

Click cells to compare fundamentals

Scynexis Account Relationship Matchups

Scynexis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	57.2M	102.5M	119.8M	87.8M	128.4M	70.4M
Short Long Term Debt Total	14.9M	19.8M	43.6M	48.6M	15.1M	25.0M
Other Current Liab	3.8M	17.6M	5.7M	11.4M	7.6M	5.7M
Total Current Liabilities	11.0M	26.4M	13.6M	17.6M	16.3M	13.7M
Total Stockholder Equity	12.9M	22.8M	41.3M	3.2M	73.0M	76.6M
Other Liab	986K	21.6M	33.6M	21.4M	24.6M	25.8M
Property Plant And Equipment Net	3.6M	3.3M	2.9M	2.6M	2.4M	2.8M
Net Debt	(27.0M)	(73.2M)	(60.9M)	2.8M	(19.4M)	(20.3M)
Retained Earnings	(271.4M)	(326.6M)	(359.5M)	(422.3M)	(355.2M)	(373.0M)
Accounts Payable	7.2M	4.6M	7.8M	5.9M	7.1M	4.3M
Cash	41.9M	93.0M	104.5M	45.8M	34.4M	42.3M
Non Current Assets Total	4.8M	4.3M	10.5M	8.7M	26.3M	27.6M
Non Currrent Assets Other	882K	760K	6.5M	5.7M	175K	166.3K
Other Assets	1.2M	1.2M	4.0M	7.7M	8.8M	9.2M
Long Term Debt	11.5M	16.5M	28.7M	45.4M	12.2M	16.9M
Cash And Short Term Investments	48.4M	93.0M	104.5M	73.5M	74.7M	57.2M
Common Stock Shares Outstanding	5.6M	10.7M	26.4M	42.6M	48.4M	50.8M
Liabilities And Stockholders Equity	57.2M	102.5M	119.8M	87.8M	128.4M	70.4M
Non Current Liabilities Total	33.2M	53.4M	65.0M	67.0M	39.1M	30.3M
Inventory	725K	520K	1.9M	463K	899K	0.0
Other Current Assets	674K	373K	4K	62K	5.5M	5.8M
Other Stockholder Equity	284.2M	349.4M	400.7M	425.5M	428.2M	280.1M
Total Liab	44.3M	79.8M	78.6M	84.6M	55.5M	44.0M
Property Plant And Equipment Gross	3.6M	3.3M	3.4M	2.6M	2.4M	2.9M
Total Current Assets	52.4M	98.2M	109.4M	79.1M	102.1M	63.5M
Property Plant Equipment	516K	405K	3.3M	113K	101.7K	96.6K
Common Stock Total Equity	48K	97K	20K	32K	36.8K	33.5K
Common Stock	97K	20K	32K	36K	40K	35K
Net Tangible Assets	31.2M	12.9M	22.8M	40.2M	36.2M	23.9M
Retained Earnings Total Equity	(217.7M)	(271.4M)	(326.6M)	(359.5M)	(323.5M)	(339.7M)
Short Term Investments	32.4M	32.7M	6.5M	27.7M	40.3M	42.3M
Capital Surpluse	248.9M	284.2M	349.4M	400.7M	460.8M	284.3M
Deferred Long Term Liab	106K	70K	187K	150K	135K	128.3K
Long Term Debt Total	10.3M	15.1M	11.5M	28.7M	33.1M	17.6M
Non Current Liabilities Other	986K	33.2M	53.4M	36.2M	41.7M	24.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Scynexis offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scynexis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scynexis Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scynexis Stock:

How To Invest In Scynexis

Details

Is Scynexis Stock a good investment?

Details

What is Scynexis' Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scynexis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Scynexis Stock please use our How to Invest in Scynexis guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Scynexis Stock analysis

When running Scynexis' price analysis, check to measure Scynexis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scynexis is operating at the current time. Most of Scynexis' value examination focuses on studying past and present price action to predict the probability of Scynexis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scynexis' price. Additionally, you may evaluate how the addition of Scynexis to your portfolios can decrease your overall portfolio volatility.

	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Commodity Directory Find actively traded commodities issued by global exchanges
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Money Managers Screen money managers from public funds and ETFs managed around the world
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk

Is Scynexis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scynexis. If investors know Scynexis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scynexis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

2.11

Revenue Per Share

2.926

Quarterly Revenue Growth

0.215

Return On Assets

0.4896

Return On Equity

0.4586

The market value of Scynexis is measured differently than its book value, which is the value of Scynexis that is recorded on the company's balance sheet. Investors also form their own opinion of Scynexis' value that differs from its market value or its book value, called intrinsic value, which is Scynexis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scynexis' market value can be influenced by many factors that don't directly affect Scynexis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Scynexis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scynexis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scynexis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Scynexis Current Deferred Revenue vs Other Stockholder Equity Analysis

Current Deferred Revenue vs Other Stockholder Equity

Current Deferred Revenue vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Other Stockholder Equity

Scynexis fundamental ratios Correlations

Scynexis Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Scynexis fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Scynexis Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Cash And Short Term Investments
Other Current Assets	+ 0.98	Net Receivables
Total Liab	+ 0.98	Non Current Liabilities Total
Cash And Short Term Investments	+ 0.95	Total Assets

Other Stockholder Equity	- 0.95	Retained Earnings
Cash	- 0.91	Net Debt
Total Current Assets	- 0.88	Retained Earnings
Retained Earnings	- 0.88	Total Assets
Accounts Payable	- 0.87	Retained Earnings
Cash And Short Term Investments	- 0.86	Retained Earnings